PROPANC BIOPHARMA, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PROPANC BIOPHARMA, INC. stock issued during period, value, other for the quarter ending 2026-03-31 was $4.62M, a 80.65% decline year-over-year.
- PROPANC BIOPHARMA, INC. stock issued during period, value, other for the quarter ending 2025-09-30 was $1.41M.
- PROPANC BIOPHARMA, INC. stock issued during period, value, other for the quarter ending 2025-03-31 was $23.88M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-03-31 | $4.62M S-1 · filed 2026-07-17 | |
| 2025-09-30 | $1.41M S-1 · filed 2026-07-17 | |
| 2025-06-30 | $51.35M S-1 · filed 2026-07-17 | |
| 2025-03-31 | $23.88M S-1 · filed 2026-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |